# Resoloy Initial Safety Evaluation

> **NCT07648017** · NA · ACTIVE_NOT_RECRUITING · sponsor: **MeKo Manufacturing e.K.** · enrollment: 10 (actual)

## Conditions studied

- CLTI Defined as Rutherford Category 4 or 5
- PAOD (Peripheral Arterial Obstructive Disease)

## Interventions

- **DEVICE:** PTA

## Key facts

- **NCT ID:** NCT07648017
- **Lead sponsor:** MeKo Manufacturing e.K.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-23
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07648017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07648017, "Resoloy Initial Safety Evaluation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07648017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*